US-based Indica Labs, an industry leader in quantitative digital pathology and image management innovations, and Lunit, a leading medical artificial intelligence (AI) software platform company focused on cancer biomarkers, have announced an agreement to provide a fully interoperable solution between Indica Labs' HALO AP image management software platform and Lunit's suite of AI pathology products. The combined solution is already in use at Guardant Health, a leading precision oncology company.

The partnership with Indica Labs, a market leader in digital pathology, with interoperable workflow integration, will enable pathologists and labs to deliver faster, more accurate, and more reproducible answers using Lunit's AI solutions.

Indica Labs developed the HALO AP platform specifically to meet the needs of anatomic pathology labs worldwide. The CE-IVD certified HALO AP platform supports a wide range of tissue-based workflows, including primary diagnosis, secondary consults, clinical trials, synoptic reporting, quantitative analytics and AI. 

By integrating South Korea-based startup Lunit's powerful AI solutions into HALO AP, pathologists and researchers can benefit from the combined capabilities of both platforms, providing them with advanced tools to help them make more informed decisions.